BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 36047877)

  • 1. Combination of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Provides Potential Biomarkers for Early-Stage Parkinson's Disease.
    Rong Y; Xu Z; Zhu Y; Zhang X; Lai L; Sun S; Gao M; Guo P; Zhang G; Geng Y; Ma X; Wu S; Yang L; Shen Z; Guan J
    ACS Chem Neurosci; 2022 Sep; 13(18):2699-2708. PubMed ID: 36047877
    [No Abstract]   [Full Text] [Related]  

  • 2. Combined Application of Quantitative Susceptibility Mapping and Diffusion Kurtosis Imaging Techniques to Investigate the Effect of Iron Deposition on Microstructural Changes in the Brain in Parkinson's Disease.
    Yang L; Cheng Y; Sun Y; Xuan Y; Niu J; Guan J; Rong Y; Jia Y; Zhuang Z; Yan G; Wu R
    Front Aging Neurosci; 2022; 14():792778. PubMed ID: 35370619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The applied value in brain gray matter nuclei of patients with early-stage Parkinson's disease : a study based on multiple magnetic resonance imaging techniques.
    Meng H; Zhang D; Sun Q
    Head Face Med; 2023 Jun; 19(1):25. PubMed ID: 37386479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Utility of quantitative susceptibility mapping and diffusion kurtosis imaging in the diagnosis of early Parkinson's disease.
    Tan S; Hartono S; Welton T; Ann CN; Lim SL; Koh TS; Li H; Setiawan F; Ng S; Chia N; Liu S; Mark Haacke E; King Tan E; Chew Seng Tan L; Ling Chan L
    Neuroimage Clin; 2021; 32():102831. PubMed ID: 34619654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Region-specific disturbed iron distribution in early idiopathic Parkinson's disease measured by quantitative susceptibility mapping.
    He N; Ling H; Ding B; Huang J; Zhang Y; Zhang Z; Liu C; Chen K; Yan F
    Hum Brain Mapp; 2015 Nov; 36(11):4407-20. PubMed ID: 26249218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron deposition in Parkinson's disease by quantitative susceptibility mapping.
    Chen Q; Chen Y; Zhang Y; Wang F; Yu H; Zhang C; Jiang Z; Luo W
    BMC Neurosci; 2019 May; 20(1):23. PubMed ID: 31117957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive microstructural alterations in subcortical nuclei in Parkinson's disease: A diffusion magnetic resonance imaging study.
    Bai X; Zhou C; Guo T; Guan X; Wu J; Liu X; Gao T; Gu L; Xuan M; Gu Q; Huang P; Song Z; Yan Y; Pu J; Zhang B; Xu X; Zhang M
    Parkinsonism Relat Disord; 2021 Jul; 88():82-89. PubMed ID: 34147950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of Diffusion Tensor Imaging and Relaxometry for the Detection of Specific Pathological Alterations in Parkinson's Disease (PD).
    Esterhammer R; Seppi K; Reiter E; Pinter B; Mueller C; Kremser C; Zitzelsberger T; Nocker M; Scherfler C; Poewe W; Schocke M
    PLoS One; 2015; 10(12):e0145493. PubMed ID: 26713760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Striatal silent lacunar infarction is associated with changes to the substantia nigra in patients with early-stage Parkinson's disease: A diffusion kurtosis imaging study.
    Zhang G; Zhang Y; Zhang C; Wang Y; Ma G; Nie K; Xie H; Liu J; Wang L
    J Clin Neurosci; 2016 Nov; 33():138-141. PubMed ID: 27499120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parkinson's disease: diffusion kurtosis imaging and the correlation with clinical manifestations].
    Sun YQ; Zhang Q; Jiang Z; Zhang CY; Zhang JW; Chen H; Shen JK
    Zhonghua Yi Xue Za Zhi; 2017 Dec; 97(45):3534-3537. PubMed ID: 29275590
    [No Abstract]   [Full Text] [Related]  

  • 12. Diffusion Kurtosis Imaging for Detection of Early Brain Changes in Parkinson's Disease.
    Guan J; Ma X; Geng Y; Qi D; Shen Y; Shen Z; Chen Y; Wu E; Wu R
    Front Neurol; 2019; 10():1285. PubMed ID: 31920913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution diffusion tensor-imaging indicates asymmetric microstructural disorganization within substantia nigra in early Parkinson's disease.
    Knossalla F; Kohl Z; Winkler J; Schwab S; Schenk T; Engelhorn T; Doerfler A; Gölitz P
    J Clin Neurosci; 2018 Apr; 50():199-202. PubMed ID: 29366621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substantia nigra locations of iron-content, free-water and mean diffusivity abnormalities in moderate stage Parkinson's disease.
    Arribarat G; Pasternak O; De Barros A; Galitzky M; Rascol O; Péran P
    Parkinsonism Relat Disord; 2019 Aug; 65():146-152. PubMed ID: 31182373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of striatonigral connectivity using probabilistic tractography in Parkinson's disease.
    Theisen F; Leda R; Pozorski V; Oh JM; Adluru N; Wong R; Okonkwo O; Dean DC; Bendlin BB; Johnson SC; Alexander AL; Gallagher CL
    Neuroimage Clin; 2017; 16():557-563. PubMed ID: 28971007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extra-basal ganglia iron content and non-motor symptoms in drug-naïve, early Parkinson's disease.
    Kim M; Yoo S; Kim D; Cho JW; Kim JS; Ahn JH; Mun JK; Choi I; Lee SK; Youn J
    Neurol Sci; 2021 Dec; 42(12):5297-5304. PubMed ID: 33860863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative evaluation of brain iron accumulation in different stages of Parkinson's disease.
    Li KR; Avecillas-Chasin J; Nguyen TD; Gillen KM; Dimov A; Chang E; Skudin C; Kopell BH; Wang Y; Shtilbans A
    J Neuroimaging; 2022 Mar; 32(2):363-371. PubMed ID: 34904328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regionally progressive accumulation of iron in Parkinson's disease as measured by quantitative susceptibility mapping.
    Guan X; Xuan M; Gu Q; Huang P; Liu C; Wang N; Xu X; Luo W; Zhang M
    NMR Biomed; 2017 Apr; 30(4):. PubMed ID: 26853890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping.
    Shahmaei V; Faeghi F; Mohammdbeigi A; Hashemi H; Ashrafi F
    Eur J Radiol Open; 2019; 6():169-174. PubMed ID: 31065578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spatiotemporal patterns of brain iron-oxygen metabolism in patients with Parkinson's disease.
    Yan S; Lu J; Li Y; Cho J; Zhang S; Zhu W; Wang Y
    Eur Radiol; 2024 May; 34(5):3074-3083. PubMed ID: 37853173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.